| Literature DB >> 28019093 |
Susanne Andres1, Rainer Ziegenhagen1, Iris Trefflich1, Sophie Pevny1, Katharina Schultrich1, Hans Braun2,3, Wilhelm Schänzer2, Karen Ildico Hirsch-Ernst1, Bernd Schäfer1, Alfonso Lampen1.
Abstract
Creatine is a popular ergogenic supplement in sports nutrition. Yet, supplementation of creatine occasionally caused adverse effects such as gastrointestinal complaints, muscle cramps and an increase in body weight. Creatine monohydrate has already been evaluated by different competent authorities and several have come to the conclusion that a daily intake of 3 g creatine per person is unlikely to pose safety concerns, focusing on healthy adults with exclusion of pregnant and breastfeeding women. Possible vulnerable subgroups were also discussed in relation to the safety of creatine. The present review provides an up-to-date overview of the relevant information with special focus on human studies regarding the safety of creatine monohydrate and other marketed creatine forms, in particular creatine pyruvate, creatine citrate, creatine malate, creatine taurinate, creatine phosphate, creatine orotate, creatine ethyl ester, creatine pyroglutamate, creatine gluconate, and magnesium creatine chelate. Limited data are available with regard to the safety of the latter creatine forms. Considering an acceptable creatine intake of 3 g per day, most of the evaluated creatine forms are unlikely to pose safety concerns, however some safety concerns regarding a supplementary intake of creatine orotate, creatine phosphate, and magnesium creatine chelate are discussed here.Entities:
Keywords: Adverse effects; Creatine; Orotate; Safety; Supplements
Mesh:
Substances:
Year: 2017 PMID: 28019093 DOI: 10.1002/mnfr.201600772
Source DB: PubMed Journal: Mol Nutr Food Res ISSN: 1613-4125 Impact factor: 5.914